Australia, Sept. 24 -- SAU CHAN TAN, owns the trademark (2666482) for 'NEULABEL' till June 26, 2036. Status: registered: Registered/protected Class: 25 [clothing; clothing, footwear, headgear; sportswear; tights; outerwear; swimwear; headbands [clothing]; T-shirts; shirts; tank tops; sweatshirts; sweaters; raincoats; cardigans; pullovers; sports jerseys; rain jackets; shell jackets; vests; ponchos; kimonos; singlets; sports singlets; slips being underclothing; underwear; panties; underpants; d...
Australia, Sept. 24 -- AstraZeneca AB, owns the trademark (2667873) for 'IGVOXIO' till June 2, 2036. Status: protected: Registered/protected Class: 5 [Pharmaceutical preparations and substances.] Type of Mark: Word Date of Acceptance: July 16 Registration Advertised: Sept. 23 For further details contact DENNEMEYER & ASSOCIATES. The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2667873. Disclaimer: Curated by HT Syndication....
Australia, Sept. 24 -- AstraZeneca AB, owns the trademark (2667883) for 'VOLZYRU' till June 2, 2036. Status: protected: Registered/protected Class: 5 [Pharmaceutical preparations and substances.] Type of Mark: Word Date of Acceptance: July 16 Registration Advertised: Sept. 23 For further details contact DENNEMEYER & ASSOCIATES. The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2667883. Disclaimer: Curated by HT Syndication....
Australia, Sept. 24 -- AstraZeneca AB, owns the trademark (2667893) for 'VOLZYLO' till June 2, 2036. Status: protected: Registered/protected Class: 5 [Pharmaceutical preparations and substances.] Type of Mark: Word Date of Acceptance: July 16 Registration Advertised: Sept. 23 For further details contact DENNEMEYER & ASSOCIATES. The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2667893. Disclaimer: Curated by HT Syndication....
Australia, Sept. 24 -- AstraZeneca AB, owns the trademark (2667976) for 'RILDANZIO' till May 22, 2036. Status: protected: Registered/protected Class: 5 [Pharmaceutical preparations and substances.] Type of Mark: Word Date of Acceptance: July 16 Registration Advertised: Sept. 23 For further details contact DENNEMEYER & ASSOCIATES. The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2667976. Disclaimer: Curated by HT Syndication....
Australia, Sept. 24 -- AstraZeneca AB, owns the trademark (2667981) for 'RILDANSIO' till May 22, 2036. Status: protected: Registered/protected Class: 5 [Pharmaceutical preparations and substances.] Type of Mark: Word Date of Acceptance: July 16 Registration Advertised: Sept. 23 For further details contact DENNEMEYER & ASSOCIATES. The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2667981. Disclaimer: Curated by HT Syndication....
Australia, Sept. 24 -- Infinite Capital LLC, owns the trademark (2667982) for 'ETERNAL' till May 6, 2036. Status: protected: Registered/protected Class: 36 [Hedge fund investment services; financial information, advisory, and consultancy services; financial services, namely, investment management, investment advice, funds investment, investment consultation and investment of funds for others; financial services, namely, operation and management of hedge funds, commodity pools and other collect...
Australia, Sept. 24 -- e.l.f. Cosmetics Inc., owns the trademark (2676351) for 'HUMIDITY HERO' till July 13, 2036. Status: registered: Registered/protected Class: 3 [hair care preparations] Type of Mark: Word Date of Acceptance: July 16 Registration Advertised: Sept. 23 For further details contact IP SOLVED (ANZ) Pty. Ltd. . The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2676351. Disclaimer: Curated by HT Syndication....
Australia, Sept. 24 -- Bristol-Myers Squibb Co., owns the trademark (2676417) for 'FUVORZONT' till July 13, 2036. Status: registered: Registered/protected Classes: 5 [Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, ...
Australia, Sept. 24 -- Bristol-Myers Squibb Co., owns the trademark (2676447) for 'ZARVOZONT' till July 13, 2036. Status: registered: Registered/protected Classes: 5 [Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, ...